CDMRP Neurofibromatosis Clinical Trial Award
The CDMRP Neurofibromatosis Clinical Trial Award is designed to support the implementation of clinical trials that aim to significantly improve the treatment or management of Neurofibromatosis, encouraging collaborations among various sectors including academia, industry, military services, and federal agencies.
$1,000,000
Closed
Nationwide
Unlock this content and more for free
Join thousands of grant professionals who trust GrantExec
βMarket insights
βExpert tips
βFunding trends
βDeep dives
Key Dates
Application Opens
June 26, 2024
Application Closes
October 3, 2024
Contact Information
Subscribe to view contact details
Newsletter Required
Categories
Science and Technology